Health & Medicine News: Recreational Marijuana Laws Not Linked to Increased Youth Marijuana Use & more...

Thu, 25 Apr 2024 19:22:03 -0700

Please click here to view this in your browser.

Recreational Marijuana Laws Not Linked to Increased Youth Marijuana Use

A recent study found that the adoption of recreational marijuana laws in the US is not associated with increased marijuana use among adolescents. The corresponding study was published in JAMA Psychiatry. As of April 2024, 24 states have legalized ...

Bipartisan Effort Demands DEA Action on Marijuana Scheduling

Marijuana is currently classified as a Schedule I drug, meaning these are “drugs with no currently accepted medical use and a high potential for abuse.” However, a team of 21 bipartisan congressional leaders from both the Senate and House of Representatives hopes to change that as they recently sent a ...

Newly Discovered Mechanism Explains How Pathogens Avoid the Immune System

Pathogens enter the body in different ways, but once inside, our immune systems detect and eliminate the foreign invaders. In some cases, pathogens find a way to survive in our body, falling below the radar of our immune cells. Certain pathogens hide inside our ...

Aspirin Reduces Cancer Progression

Aspirin is an over-the-counter medication used to reduce swelling and relieve pain. It is a salicylate medication, which means it reduces the formation of prostaglandins, which are critical in the process of inflammation, and prevents the formation of platelets. In general, it is given to reduce fever and help ...

Game-Changing New Receptor Unlocks the Potential of CAR-T Cell Therapy

Exciting cancer therapy innovations were announced in Cell Reports Medicine in the realm CAR-T-cell therapy (chimeric antigen receptor T cell). By designing a new cytokine receptor, Yoshikawa et al. of Keio University in Tokyo have elevate the efficacy and ...

UPCOMING WEBINARS

Certified, Sustainable and Safe Ductless Air Filtration Solutions

Jesse Coiro - Bio: Jesse Coiro leads Erlab as Director of NA Operations, overseeing the company's strategic vision, product development, and operations. He has over 25 years of experience in the biopharma, pharmaceutical, medical device, and educational markets providing air filtration solutions to increase protection of personnel, facilities, and the environment.

Creating a lab with Ductless Air Filtration Solutions that provides certified, sustainable, safety wherever your science takes you.

MAY 03, 2024 3:30 PM EDT

Is It Anti-RNP or Anti-Sm/RNP?

Dr. Lisa K. Peterson, Ph.D., D(AMBLI) - Assoc. Prof. of Pathology (Clinical) at the University of Utah and Medical Director of Immunology, ARUP Laboratories

Antibodies against ribonucleoprotein (RNP) are an important serologic marker for mixed connective tissue disease (MCTD). RNP interacts with Smith (Sm) proteins to form the Sm/RNP complex. Antigens for detecting U1-RNP antibody may include purified extracts (Sm/RNP complex), recombinant proteins, synthetic peptides, or dominant epitopes of the three main proteins (RNPA, RNPC, and RNP68/RNP70) ...

MAY 07, 2024 8:00 AM PDT

Advancing cancer organoid drug screening with novel media systems

Dr. Christophe Deben, Ph.D. Oncology and Cancer Biology - Professor Tumor Biology and Organoids, University of Antwerp

Dr. Colin Paul - Cell Biology R&D Staff Scientist, Thermo Fisher Scientific.

Explore the latest developments in cancer organoid (tumoroid) technology and the promising implications for drug screening during this two-part webinar. In the first half, Colin Paul will discuss the capabilities of OncoPro medium, a novel system that simplifies the use of tumoroids for drug screening applications. This session will review potential areas of optimization and highlight how OncoPro ...

MAY 08, 2024 7:00 AM PDT

Overcoming Challenges with AAA Aggregate Analysis Using a Novel SEC Column to Determine Critical Quality Attributes

Shilin Cheung, Ph.D. - Sr. Research Scientist, Phenomenex Inc

As the most widely used viral vector for gene therapies, Adeno-Associated Viruses (AAVs) present unique advantages, including their ability to enter both dividing and non-dividing cells, the absence of human viral illness, and minimal immune response triggers. However, the complexity and size of AAVs pose challenges for their analysis. Traditional approaches struggle with their larger ...

MAY 08, 2024 8:00 AM PDT

See More Webinars

SCIENTIFIC PRODUCTS

CREATIVE BIOLABS

Mouse Anti-gp41 (HIV-1) Recombinant Antibody...

SANTA CRUZ BIOTECHNOLOGY

CD133 HDR Plasmid (m)

MAXCYTE

ExPERT STx™ Scalable static or flow electroporation

LEICA BIOSYSTEMS

Leica VT1000 S vibrating blade microtome

PHENOMENEX